Thousand Oaks-based Amgen Inc. posted second-quarter profit that topped analysts’ estimates, driven by higher sales and lower operating expenses. The biotech also raised its revenue and earnings forecast for the year. Profit excluding one-time items rose to $2.57 a share, while analysts had predicted $2.43 on average. Revenue increased 3.7 percent to $5.37 billion, the Read More →
UC Santa Barbara’s Institute for Energy Efficiency will play a lead role in a $110 million federal program to develop new electronic products using the next generation of chip technology. UCSB will become the west coast hub for the newly formed American Institute for Manufacturing of Photonics (AIM), teaming with lead institution State University of Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Thousand Oaks-based Amgen announced Thursday that it submitted data comparing its new multiple-myeloma drug against a rival to the Food and Drug Administration. Kyprolis is Amgen’s new treatment for multiple-myeloma, which is a form of blood cancer that forms in plasma cells and typically grows in bone marrow. The drug was approved for third-line treatments Read More →
Teledyne Technologies won an out of this world contract Tuesday. Thousand Oaks-based Teledyne announced that it won a $15 million contract from NASA on Monday to build a hyper-spectral remote sensing imaging instrument that will be used on the International Space Station. Teledyne makes instrumentation, digital imaging products and software for aerospace and defense systems. Read More →
With all of the talk about hacking of big business and government, it’s time for small business owners to access their own vulnerabilities and design a plan of action. If they do not tackle this head on, small business owners risk the possibility of significant financial loss, litigation or even business failure. Ignorance is not Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.